Tag:
Sigma-Tau
Latest Headlines
Latest Headlines
Family owners eye bids for Italy's Rottapharm
On the heels of last week's news that family-owned Italian drugmaker Sigma Tau was up for sale, the family-owned Italian drugmaker Rottapharm|Madaus has hit the auction block, the Wall Street Journal
Private equity funds eye Sigma-Tau stake
Even before the death of its founder Claudio Cavazza in June, Italian drugmaker Sigma-Tau was mulling its strategic options. Now, sources tell Bloomberg the Cavazza family is leaning toward selling a
Report: Sigma-Tau may sell a stake in company
Bloomberg cites sources close to Italy's Sigma-Tau who say that the company is considering selling a stake in the biotech following the death of its founder. Four Partners is advising the company,
Italy's Sigma-Tau eyes sale of minority stake
Shopping for a drug-company stake? Almost half of Sigma-Tau may soon be available. A member of the Cavazza clan that owns the Italian drugmaker is looking at selling his 38 percent share, a move that
Pfizer jobs safe...through holidays
Pfizer's head of worldwide discovery research, Rod MacKenzie, communicated to employees that more research jobs will be on the chopping block, just as analysts predict ed, but he said he wouldn't be
SciClone's hep C drug fails late-stage trial
SciClone Pharmaceuticals' late-stage therapy for hepatitis C failed to hit a primary endpoint in a late-stage trial. The drug, thymalfasin, failed to register a significant response in patients who
